MAPT and amyloidosis: Plasma p‐tau217 showed the strongest correlations with CSF p‐tau181 and t‐tau (R2 > 0.4, P < 0.001), particularly in amyloid‐positive individuals, consistent with previous studies linking p‐tau217 to tau and amyloid pathology.47, 48, 49